{"entity":{"id":"nct06828354","kind":"trial","name":"A Study of SHR-A1811 in Subjects With Ovarian Cancer","aka":[],"tldr":"A phase 3 trial of Trastuzumab rezetecan, Paclitaxel / nab-paclitaxel, Gemcitabine in ovarian cancer, run by Jiangsu HengRui Medicine Co., Ltd., now recruiting.","summary":"A Study of SHR-A1811 in Subjects With Ovarian Cancer is a phase 3 interventional study registered as NCT06828354 by Jiangsu HengRui Medicine Co., Ltd., with 300 participants planned, started 2025-03-13 and due to reach its primary completion in 2027-05. Interventions recorded: SHR-A1811, Paclitaxel Injection, Doxorubicin Hydrochloride Liposome Injection, Gemcitabine Hydrochloride for Injection, Topotecan Hydrochloride for Injection. Conditions listed: Ovarian Cancer. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06828354","url":"https://clinicaltrials.gov/study/NCT06828354"}],"tags":["ctgov-ingest"],"related":[],"cancers":["ovarian"],"sections":[],"technologies":[],"targets":[],"drugs":["trastuzumab-rezetecan","paclitaxel","gemcitabine","topotecan"],"companies":["hengrui"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06828354","phase":"3","setting":"An Open-label, Randomized, Multicenter Phase III Clinical Trial of SHR-A1811 Versus Investigator-selected Chemotherapy for Platinum-resistant Relapsed Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","enrolled":300,"outcomes":[]},"route":"/trials/nct06828354/","neighbours":{"cancer":[{"id":"ovarian","kind":"cancer","name":"Ovarian cancer","route":"/cancers/ovarian/"}],"drug":[{"id":"gemcitabine","kind":"drug","name":"Gemcitabine","route":"/drugs/gemcitabine/"},{"id":"paclitaxel","kind":"drug","name":"Paclitaxel / nab-paclitaxel","route":"/drugs/paclitaxel/"},{"id":"topotecan","kind":"drug","name":"Topotecan","route":"/drugs/topotecan/"},{"id":"trastuzumab-rezetecan","kind":"drug","name":"Trastuzumab rezetecan","route":"/drugs/trastuzumab-rezetecan/"}],"company":[{"id":"hengrui","kind":"company","name":"Jiangsu Hengrui Pharmaceuticals","route":"/companies/hengrui/"}]}}